• Amgen offers $167m to acquire Nuevolution pharmaceutical-technology
    May 24, 2019
    Amgen has made a public offer to buy Denmark-based biopharmaceutical company Nuevolution for a cash consideration of around $167m.
PharmaSources Customer Service